Literature DB >> 1688458

Autonomic receptors in human prostate adenomas.

D I Gup1, E Shapiro, M Baumann, H Lepor.   

Abstract

Radioligand receptor binding techniques were used to characterize alpha 1 adrenergic, alpha 2 adrenergic and muscarinic cholinergic (MCh) binding sites in human prostate adenomas obtained from men with symptomatic and asymptomatic benign prostatic hyperplasia (BPH). Prostate adenoma specimens were obtained from nine men with asymptomatic BPH undergoing cystoprostatectomy, 11 men with symptomatic BPH undergoing open prostatectomy, and 11 men with symptomatic BPH undergoing transurethral resection of the prostate (TURP). A quantitative symptoms score analysis and urinary flow rate determinations documented the absence of bladder outlet obstruction in men undergoing cystoprostatectomy and confirmed the presence of bladder outlet obstruction in men undergoing prostatectomy. The mean equilibrium dissociation constants (Kd) and the mean densities of 125I-Heat (alpha 1 adrenergic) and 3H-NMS (MCh) binding sites were similar in tissue homogenates obtained from men with asymptomatic and symptomatic BPH. The mean Kd of 3H-Rauwolscine (3H-Ra) was significantly greater in the prostatectomy specimens obtained from men with symptomatic BPH compared to the specimens obtained from men with asymptomatic BPH (p less than 0.05). The density of 3H-Ra (alpha 2 adrenergic) binding sites was significantly greater in the prostate adenomas obtained from men with symptomatic BPH compared to the prostate adenomas obtained from men with asymptomatic BPH (p less than 0.05). The difference in alpha 2 adrenoceptor density was accounted for by an increased receptor density in the open prostatectomy specimens. There was no significant correlation between alpha 2 adrenergic, alpha 1 adrenergic, and MCh receptor densities and prostate weight or patient age. This study indicates that the development of infravesical obstruction in men with BPH is not related to upregulation or altered binding affinity of alpha 1 adrenergic or MCh receptor binding sites. The significance of the observed upregulation of alpha 2 adrenoreceptors in the prostate adenomas obtained from men undergoing open prostatectomy is unknown, and requires further investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688458     DOI: 10.1016/s0022-5347(17)39906-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  11 in total

1.  Pathophysiology of lower urinary tract symptoms in the aging male population.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

2.  Pathophysiology of benign prostatic hyperplasia in the aging male population.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

Review 3.  Management of bladder, prostatic and pelvic floor disorders.

Authors:  G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

4.  Alfuzosin, a selective alpha 1-adrenoceptor antagonist in the lower urinary tract.

Authors:  F Lefèvre-Borg; S E O'Connor; H Schoemaker; P E Hicks; J Lechaire; E Gautier; F Pierre; C Pimoule; P Manoury; S Z Langer
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Muscarinic receptor subtype mRNA expression in the human prostate: association with age, pathological diagnosis, prostate size, or potentially interfering medications?

Authors:  Lambertus P W Witte; Christine A Teitsma; Jean J M C H de la Rosette; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-06       Impact factor: 3.000

6.  A possible role of decreased relaxation mediated by beta-adrenoceptors in bladder outlet obstruction by benign prostatic hyperplasia.

Authors:  T Tsujii; H Azuma; T Yamaguchi; H Oshima
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

7.  Pharmacological evidence of distinct alpha 1-adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery.

Authors:  A Hatano; H Takahashi; M Tamaki; T Komeyama; T Koizumi; M Takeda
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

Review 8.  Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Authors:  Martin C Michel; Wim Vrydag
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

9.  Norepinephrine contents of human prostatic hyperplasia: differences between pathological subtypes.

Authors:  M Ishigooka; S Hayami; M Tomaru; T Hashimoto; I Sasagawa; T Nakada
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

10.  G-proteins in alpha 1-adrenoceptor mediated prostatic smooth muscle contraction.

Authors:  P Drescher; R E Eckert; P O Madsen
Journal:  Urol Res       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.